Regulation Of US Supplement Industry Needs ‘Really Hard Look’ – FDA's Woodcock

It’s known that the US Food and Drug Administration needs more information to determine whether hemp-derived cannabinoids are safe for dietary supplements. It also should be known, says acting Commissioner Janet Woodcock, that the agency needs to evaluate its oversight of all supplement manufacturing and marketing.

Woodcock’s comment on the FDA’s regulation of the vitamin, mineral and supplement product industry was her most definite statement about the agency’s work in the consumer health sector during her keynote address opening the